-
Track & Monitor
NewImmuno-oncology in pharma: neoepitope prediction
Why settle for outdated information when you can stay ahead of the curve with our comprehensive report? Our team of industry experts has meticulously researched and analyzed the latest trends, innovations, and emerging technologies in the pharma industry’s neoepitope prediction within Immuno-oncology innovations. By leveraging our report, you'll gain invaluable insights that can revolutionize your business strategies and give you a competitive edge. Why Choose Our Report? Unparalleled Expertise: Our research team consists of seasoned analysts with deep knowledge and...
-
Thematic Analysis
NewDigital Marketing Trends in Non-small Cell Lung Cancer
Merck’s Keytruda.com achieved the highest total traffic across non-small cell lung cancer (NSCLC) patient sites in the US, with over 2.4 million visitors from October 2022 to September 2023. This was followed by BMS's Opdivo.com (1.7 million visits) and AstraZeneca's Imfinzi.com (350,000). Keytruda.com was also supported by the most paid search engine optimization (SEO) at over 7,600 keywords, closely followed by Enhertu.com (6,640) and Opdivo.com (5,840). Overall, the highest proportion of traffic to top branded patient NSCLC websites originated from direct and organic sources. AstraZeneca’s...
-
Track & Monitor
NewInnovation in pharma: transdermal drug delivery
Why settle for outdated information when you can stay ahead of the curve with our comprehensive report? Our team of industry experts has meticulously researched and analyzed the latest trends, innovations, and emerging technologies in the pharma industry’s transdermal drug delivery innovations. By leveraging our report, you'll gain invaluable insights that can revolutionize your business strategies and give you a competitive edge. Why Choose Our Report? Unparalleled Expertise: Our research team consists of seasoned analysts with deep knowledge and experience...
-
Track & Monitor
NewInnovation in Pharmaceuticals: Platinum as active pharmaceutical ingredient
Innovation in the pharmaceuticals industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts, posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in pharmaceuticals industry. Using patents data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating...
-
Product Insights
NewCervical Cancer Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
GlobalData's clinical trial report, “Cervical Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update" provides an overview of Cervical Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on Cervical Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 &...
-
Product Insights
NewSeasonal Influenza Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
GlobalData's clinical trial report, “Seasonal Influenza Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update" provides an overview of Seasonal Influenza Clinical trials scenario. This report provides top line data relating to the clinical trials on Seasonal Influenza. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 &...
-
Product Insights
NewPolymyositis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
GlobalData's clinical trial report, “Polymyositis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update" provides an overview of Polymyositis Clinical trials scenario. This report provides top line data relating to the clinical trials on Polymyositis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial...
-
Product Insights
NewRespiratory Syncytial Virus (RSV) Infections Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
GlobalData's clinical trial report, “Respiratory Syncytial Virus (RSV) Infections Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update" provides an overview of Respiratory Syncytial Virus (RSV) Infections Clinical trials scenario. This report provides top line data relating to the clinical trials on Respiratory Syncytial Virus (RSV) Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage...
-
Product Insights
NewPeripheral Artery Occlusive Disease (PAOD) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
GlobalData's clinical trial report, “Peripheral Artery Occlusive Disease (PAOD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update" provides an overview of Peripheral Artery Occlusive Disease (PAOD) Clinical trials scenario. This report provides top line data relating to the clinical trials on Peripheral Artery Occlusive Disease (PAOD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage...
-
Product Insights
NewInterstitial Cystitis (Painful Bladder Syndrome) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
GlobalData's clinical trial report, “Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update" provides an overview of Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) Clinical trials scenario. This report provides top line data relating to the clinical trials on Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome). Report includes an overview of trial numbers and their average enrollment in top countries conducted across...
Testimonial
Your Drugs database is great, you can find all the information you want such as sales forecasts, countries, diseases, dates, clinical trials, and patent expiration. We are using this information to research the leading competitive products in our current project. In addition, we analyze the profiles of the leading products and use this information to set the differentiation profile of our own products and clarify our positioning. In terms of business forecasts, we are able to provide more objective figures by using the Drug Forecast and Market Analysis report series. The analysis of product share by disease (series of Drug Forecast and Market Analysis reports) is used for business feasibility assessment.”
The ability to evaluate or provide information on PJs in R&D from both product and disease perspectives (it is difficult to find a database that can be used comprehensively for both), stands GlobalData out from other providers. The release of new functions such as Likelihood of approval (LoA) analysis, which was something I wanted but did not exist, shows that GlobalData have done a good job of researching the industry and developing services from the customer’s perspective which is another positive.
GlobalData’s COVID-19 Bulletin, which is sent out several times a week, provides the latest information on COVID-19 related vaccines and therapeutics and is used as background information.
“GlobalData provides extensive and comprehensive Pharma and Biotech data along with spectacular customer support. I use their drug, trial and company data on a daily basis to support our sales and marketing efforts.”
“As a global biopharma R&D strategy consultancy, we use the GlobalData Pharma Intelligence platform across a broad spectrum of topics, it provides all key data in one place”